[{"Assets_0_Q1_USD":44355600000.0,"CIK":"59478","CommonStockDividendsPerShareCashPaid_1_Q1_USD":0.5625,"Country":"United States","EarningsPerShareBasic_1_Q1_USD":1.16,"EarningsPerShareDiluted_1_Q1_USD":1.16,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"282857000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":436500000.0,"NetIncomeLossConverted_1_Q1_USD":1217400000.0,"OfficialName":"Eli Lilly and Company Common Stock","RevenuesConverted_1_Q1_USD":5700000000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":14587800000.0,"StockholdersEquity_0_Q1_USD":14527000000.0,"Ticker":"LLY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":1049800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1048000000.0,"filed":"20180427","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2018.0","name":"LILLY ELI & CO","period":"20180331","qtrs":"0","uom":"USD"}]